SludgeReports (SR) has been following the Biotime story for a few years now and recommended it recently as a long term buy and hold.
Recent news items include placement of up to $30 million of stock with institutions and insiders. Neal Bradsher, a Director and large shareholder, scooped up an additional 4 million of those shares.
Now Mike Mulroy and Steve Cartt are joining the team! These Questcor veterans add even more credibility to an already phenomenal story unfolding.
It would not surprise SR to find out Mulroy and Cartt also took part in the share purchase.
Keep this one on your radar folks! This is a serious team with a lot of experience in the industry and capital markets.